ijerph-logo

Journal Browser

Journal Browser

Anxiety and Depressive Disorders among Pregnant and Breastfeeding Women

A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Behavioral and Mental Health".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 1311

Special Issue Editor


E-Mail Website
Guest Editor
Emergency Department, Poison Control Center, Hospital Papa Giovanni XXIII, 24100D Bergamo, Italy
Interests: depression; anxiety disorder; pregnancy; breastfeeding; antidepressants; anxiolytics

Special Issue Information

Dear Colleagues,

Depression and anxiety disorders are the most common psychiatric morbidities in pregnancy and, in particular, after delivery. However, there are still errors and shortcomings among healthcare professionals in the recognition, diagnosis and treatment of depression during pregnancy and in the postpartum stage, with resulting consequences and repercussions for the gestation itself or the fetus or neonate. These women have a poor quality of life, and they are more likely to smoke or use alcohol or other substances, which may worsen the pregnancy outcome or the need to breastfeed. Indeed, the use of antidepressant and anxiolytic drugs during pregnancy and postpartum may constitute a potential risk to the fetus or neonate but are also a clear benefit for patients with depression already manifested during pregnancy or for those with a new onset of postpartum depression. Moreover, the abrupt discontinuation of antidepressants may be associated with relapses/recurrences. The art of medicine is exemplified by balancing the risks of untreated psychiatric disorders such as depressive symptoms during pregnancy or breastfeeding and the risks of adverse fetal or neonatal outcomes associated with exposure to antidepressants or anxiolytic medicines. Papers addressing these topics are invited to be submitted to this Special Issue, especially those combining a high level of academic experience in women’s mental health, in neonatal complications and in the use of drugs in pregnancy and lactation coupled with a practical focus on providing excellent management of the disease.

Dr. Georgios Eleftheriou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • depression
  • anxiety disorder
  • pregnancy
  • breastfeeding
  • antidepressants
  • anxiolytics

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

17 pages, 385 KiB  
Review
Depression Treatment in Pregnancy: Is It Safe, or Is It Not?
by Vitalba Gallitelli, Rita Franco, Sofia Guidi, Ludovica Puri, Marco Parasiliti, Annalisa Vidiri, Georgios Eleftheriou, Federica Perelli and Anna Franca Cavaliere
Int. J. Environ. Res. Public Health 2024, 21(4), 404; https://doi.org/10.3390/ijerph21040404 - 26 Mar 2024
Viewed by 1089
Abstract
Prenatal depression carries substantial risks for maternal and fetal health and increases susceptibility to postpartum depression. Untreated depression in pregnancy is correlated with adverse outcomes such as an increased risk of suicidal ideation, miscarriage and neonatal growth problems. Notwithstanding concerns about the use [...] Read more.
Prenatal depression carries substantial risks for maternal and fetal health and increases susceptibility to postpartum depression. Untreated depression in pregnancy is correlated with adverse outcomes such as an increased risk of suicidal ideation, miscarriage and neonatal growth problems. Notwithstanding concerns about the use of antidepressants, the available treatment options emphasize the importance of specialized medical supervision during gestation. The purpose of this paper is to conduct a brief literature review on the main antidepressant drugs and their effects on pregnancy, assessing their risks and benefits. The analysis of the literature shows that it is essential that pregnancy be followed by specialized doctors and multidisciplinary teams (obstetricians, psychiatrists and psychologists) who attend to the woman’s needs. Depression can now be treated safely during pregnancy by choosing drugs that have no teratogenic effects and fewer side effects for both mother and child. Comprehensive strategies involving increased awareness, early diagnosis, clear guidelines and effective treatment are essential to mitigate the impact of perinatal depression. Full article
Back to TopTop